These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 4-quinolones and the physiology of DNA gyrase. Drlica K, Kreiswirth B. Adv Pharmacol; 1994; 29A():263-83. PubMed ID: 7826862 [No Abstract] [Full Text] [Related]
3. Quinolones: pharmacology. Verbist L. Pharm Weekbl Sci; 1986 Feb 21; 8(1):22-5. PubMed ID: 3008075 [Abstract] [Full Text] [Related]
4. Mechanism of action of the des-F(6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays. Wu P, Lawrence LE, Denbleyker KL, Barrett JF. Antimicrob Agents Chemother; 2001 Dec 21; 45(12):3660-2. PubMed ID: 11709365 [Abstract] [Full Text] [Related]
5. Mode of action of the new quinolones: new data. Hooper DC, Wolfson JS. Eur J Clin Microbiol Infect Dis; 1991 Apr 21; 10(4):223-31. PubMed ID: 1650698 [Abstract] [Full Text] [Related]
6. Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and topoisomerase II of fetal calf thymus. Hoshino K, Sato K, Une T, Osada Y. Antimicrob Agents Chemother; 1989 Oct 21; 33(10):1816-8. PubMed ID: 2556080 [Abstract] [Full Text] [Related]
7. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance. Fisher LM, Lawrence JM, Josty IC, Hopewell R, Margerrison EE, Cullen ME. Am J Med; 1989 Nov 30; 87(5A):2S-8S. PubMed ID: 2574005 [Abstract] [Full Text] [Related]
11. New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay. Domagala JM, Hanna LD, Heifetz CL, Hutt MP, Mich TF, Sanchez JP, Solomon M. J Med Chem; 1986 Mar 30; 29(3):394-404. PubMed ID: 3005575 [Abstract] [Full Text] [Related]
12. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage. Chen CR, Malik M, Snyder M, Drlica K. J Mol Biol; 1996 May 17; 258(4):627-37. PubMed ID: 8636997 [Abstract] [Full Text] [Related]
13. Quinolone-resistant mutations of DNA gyrase increase sensitivity to acriflavine. Funatsuki K, Tanaka R, Inagaki S, Konno H, Katoh K, Nakamura H. Biol Pharm Bull; 1998 Jul 17; 21(7):667-72. PubMed ID: 9703246 [Abstract] [Full Text] [Related]
14. Molecular mechanisms of DNA gyrase inhibition by quinolone antibacterials. Shen LL. Adv Pharmacol; 1994 Jul 17; 29A():285-304. PubMed ID: 7826863 [No Abstract] [Full Text] [Related]
15. [Gyrase inhibitor]. Forth W. Klin Wochenschr; 1985 Oct 01; 63(19):1036-9. PubMed ID: 2999503 [No Abstract] [Full Text] [Related]
16. Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis. Onodera Y, Tanaka M, Sato K. J Antimicrob Chemother; 2001 Apr 01; 47(4):447-50. PubMed ID: 11266418 [Abstract] [Full Text] [Related]
18. DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance. Zhao X, Xu C, Domagala J, Drlica K. Proc Natl Acad Sci U S A; 1997 Dec 09; 94(25):13991-6. PubMed ID: 9391140 [Abstract] [Full Text] [Related]
19. Ofloxacin, a bactericidal antibacterial. Smith JT. Chemotherapy; 1991 Dec 09; 37 Suppl 1():2-13. PubMed ID: 1646700 [Abstract] [Full Text] [Related]